Tower Research Capital LLC (TRC) - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 23 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q4 2015$10,000
+25.0%
6,008
+230.8%
0.00%
+100.0%
Q4 2014$8,000
+33.3%
1,816
+26.0%
0.00%0.0%
Q3 2014$6,0001,4410.00%
Q1 2014$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2013$31,0003,2860.01%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q4 2013
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$27,357,0009.71%
First Washington CORP 194,440$1,145,0000.64%
SPHERA FUNDS MANAGEMENT LTD. 200,000$1,178,0000.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,669,0000.06%
EMERALD ADVISERS, LLC 175,000$1,031,0000.06%
Pine River Capital Management L.P. 209,900$1,236,0000.02%
Alyeska Investment Group, L.P. 82,943$489,0000.01%
TFS CAPITAL LLC 19,147$113,0000.01%
HighTower Advisors, LLC 66,514$392,0000.01%
DRIEHAUS CAPITAL MANAGEMENT LLC 32,143$189,0000.01%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders